Home Casteddu.com	FAQ My Amedeo About	Flying Publisher
	The Medical Article of the Year 2008: Wellcome Trust Case Control Consortium. Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls. Nature 2007; 447:661-78. Free full-text

Prostate Cancer

Free Subscription Articles published in Prostate Retrieve available abstracts of 288 articles: HTML format

Single Articles

June 2008
1. THOMAS R , Kim MH
   HIF-1alpha: A key survival factor for serum-deprived prostate cancer cells.
   Prostate. 2008;.
   PubMed     Related articles    Abstract available
   
   
   
2. HALL CL , Daignault SD, Shah RB, Pienta KJ, et al
   Dickkopf-1 expression increases early in prostate cancer development and decreases during progression from primary tumor to metastasis.
   Prostate. 2008;.
   PubMed     Related articles    Abstract available
   
   
   
3. HARRIS TJ , Hipkiss EL, Borzillary S, Wada S, et al
   Radiotherapy augments the immune response to prostate cancer in a time-dependent manner.
   Prostate. 2008;.
   PubMed     Related articles    Abstract available
   
   
   
4. MARKS RA , Zhang S, Montironi R, McCarthy RP, et al
   Epidermal growth factor receptor (EGFR) expression in prostatic adenocarcinoma after hormonal therapy: a fluorescence in situ hybridization and immunohistochemical analysis.
   Prostate. 2008;68:919-23.
   PubMed     Related articles    Abstract available
   
   
   
5. SHEPHERD CJ , Rizzo S, Ledaki I, Davies M, et al
   Expression profiling of CD133+ and CD133- epithelial cells from human prostate.
   Prostate. 2008;68:1007-24.
   PubMed     Related articles    Abstract available
   
   
   
6. CORTESI M , Fridman E, Volkov A, Shilstein SSh, et al
   Clinical assessment of the cancer diagnostic value of prostatic zinc: a comprehensive needle-biopsy study.
   Prostate. 2008;68:994-1006.
   PubMed     Related articles    Abstract available
   
   
   
7. LIU T , Wu LY, Kazak M, Berkman CE, et al
   Cell-Surface labeling and internalization by a fluorescent inhibitor of prostate-specific membrane antigen.
   Prostate. 2008;68:955-64.
   PubMed     Related articles    Abstract available
   
   
   
8. LI W , Liu X, Wang W, Sun H, et al
   Effects of antisense RNA targeting of ODC and AdoMetDC on the synthesis of polyamine synthesis and cell growth in prostate cancer cells using a prostatic androgen-dependent promoter in adenovirus.
   Prostate. 2008;.
   PubMed     Related articles    Abstract available
   
   
   
9. POLASCIK TJ , Mayes JM, Sun L, Madden JF, et al
   Pathologic stage T2a and T2b prostate cancer in the recent prostate-specific antigen era: Implications for unilateral ablative therapy.
   Prostate. 2008;.
   PubMed     Related articles    Abstract available
   
   
   
10. WEI S , Dunn TA, Isaacs WB, De Marzo AM, et al
    GOLPH2 and MYO6: Putative prostate cancer markers localized to the Golgi apparatus.
    Prostate. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
11. FITZGERALD LM , Thomson R, Polanowski A, Patterson B, et al
    Sequence variants of alpha-methylacyl-CoA racemase are associated with prostate cancer risk: A replication study in an ethnically homogeneous population.
    Prostate. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
12. FUJITA K , Ewing CM, Sokoll LJ, Elliott DJ, et al
    Cytokine profiling of prostatic fluid from cancerous prostate glands identifies cytokines associated with extent of tumor and inflammation.
    Prostate. 2008;68:872-82.
    PubMed     Related articles    Abstract available
    
    
    
13. HALLSTROM TM , Laiho M
    Genetic changes and DNA damage responses in the prostate.
    Prostate. 2008;68:902-18.
    PubMed     Related articles    Abstract available
    
    
    
14. BAO BY , Chuang BF, Wang Q, Sartor O, et al
    Androgen receptor mediates the expression of UDP-glucuronosyltransferase 2 B15 and B17 genes.
    Prostate. 2008;68:839-48.
    PubMed     Related articles    Abstract available
    
    
    May 2008
15. HAYASHI N , Koller E, Fazli L, Gleave ME, et al
    Effects of Eg5 knockdown on human prostate cancer xenograft growth and chemosensitivity.
    Prostate. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
16. KIM MH , Field J
    Translationally regulated C/EBPbeta isoform expression upregulates metastatic genes in hormone-independent prostate cancer cells.
    Prostate. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
17. LAI TH , Fong YC, Fu WM, Yang RS, et al
    Osteoblasts-derived BMP-2 enhances the motility of prostate cancer cells via activation of integrins.
    Prostate. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
18. PETERNAC D , Klima I, Cecchini MG, Schwaninger R, et al
    Agents used for chemoprevention of prostate cancer may influence PSA secretion independently of cell growth in the LNCaP model of human prostate cancer progression.
    Prostate. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
19. STEVENS VL , Rodriguez C, Talbot JT, Pavluck AL, et al
    Paraoxonase 1 (PON1) polymorphisms and prostate cancer in the CPS-II Nutrition Cohort.
    Prostate. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
20. THOMPSON M , Lapointe J, Choi YL, Ong DE, et al
    Identification of candidate prostate cancer genes through comparative expression-profiling of seminal vesicle.
    Prostate. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
21. RYAN CJ , Zavodovskaya M, Youngren JF, Campbell M, et al
    Inhibitory effects of nordihydroguaiaretic acid (NDGA) on the IGF-1 receptor and androgen dependent growth of LAPC-4 prostate cancer cells.
    Prostate. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
22. SUN J , Chang BL, Isaacs SD, Wiley KE, et al
    Cumulative effect of five genetic variants on prostate cancer risk in multiple study populations.
    Prostate. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
23. CAO W , Yacoub S, Shiverick KT, Namiki K, et al
    Dichloroacetate (DCA) sensitizes both wild-type and over expressing Bcl-2 prostate cancer cells in vitro to radiation.
    Prostate. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
24. THUDI NK , Martin CK, Nadella MV, Fernandez SA, et al
    Zoledronic acid decreased osteolysis but not bone metastasis in a nude mouse model of canine prostate cancer with mixed bone lesions.
    Prostate. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
25. WHITAKER HC , Girling J, Warren AY, Leung H, et al
    Alterations in beta-catenin expression and localization in prostate cancer.
    Prostate. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
26. KIBEL AS , Jin CH, Klim A, Luly J, et al
    Association between polymorphisms in cell cycle genes and advanced prostate carcinoma.
    Prostate. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
27. PRUEITT RL , Yi M, Hudson RS, Wallace TA, et al
    Expression of microRNAs and protein-coding genes associated with perineural invasion in prostate cancer.
    Prostate. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
28. ISHARWAL S , Miller MC, Marlow C, Makarov DV, et al
    p300 (histone acetyltransferase) biomarker predicts prostate cancer biochemical recurrence and correlates with changes in epithelia nuclear size and shape.
    Prostate. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
29. PIERCE BL , Plymate S, Ostrander EA, Stanford JL, et al
    Diabetes mellitus and prostate cancer risk.
    Prostate. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
30. MASSONER P , Haag P, Seifarth C, Jurgeit A, et al
    Insulin-like growth factor binding protein-3 (IGFBP-3) in the prostate and in prostate cancer: Local production, distribution and secretion pattern indicate a role in stromal-epithelial interaction.
    Prostate. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
31. RAMBERG H , Eide T, Krobert KA, Levy FO, et al
    Hormonal regulation of beta(2)-adrenergic receptor level in prostate cancer.
    Prostate. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
32. MARUYAMA-TAKAHASHI K , Shimada N, Imada T, Maekawa-Tokuda Y, et al
    A neutralizing anti-fibroblast growth factor (FGF) 8 monoclonal antibody shows anti-tumor activity against FGF8b-expressing LNCaP xenografts in androgen-dependent and -independent conditions.
    Prostate. 2008;68:640-50.
    PubMed     Related articles    Abstract available
    
    
    
33. TSUI KH , Hsieh WC, Lin MH, Chang PL, et al
    Triiodothyronine modulates cell proliferation of human prostatic carcinoma cells by downregulation of the B-cell translocation gene 2.
    Prostate. 2008;68:610-9.
    PubMed     Related articles    Abstract available
    
    
    April 2008
34. BERTILACCIO MT , Grioni M, Sutherland BW, Degl'innocenti E, et al
    Vasculature-targeted tumor necrosis factor-alpha increases the therapeutic index of doxorubicin against prostate cancer.
    Prostate. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
35. ABRIL J , de Heredia ML, Gonzalez L, Cleries R, et al
    Altered expression of 12S/MT-RNR1, MT-CO2/COX2, and MT-ATP6 mitochondrial genes in prostate cancer.
    Prostate. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
36. GOSSELAAR C , Kranse R, Roobol MJ, Roemeling S, et al
    The interobserver variability of digital rectal examination in a large randomized trial for the screening of prostate cancer.
    Prostate. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
37. WU Z , Gioeli D, Conaway M, Weber MJ, et al
    Restoration of PTEN expression alters the sensitivity of prostate cancer cells to EGFR inhibitors.
    Prostate. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
38. MEHRAEIN-GHOMI F , Lee E, Church DR, Thompson TA, et al
    JunD mediates androgen-induced oxidative stress in androgen dependent LNCaP human prostate cancer cells.
    Prostate. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
39. INOUE T , Leman ES, Yeater DB, Getzenberg RH, et al
    The potential role of purine-rich element binding protein (PUR) alpha as a novel treatment target for hormone-refractory prostate cancer.
    Prostate. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
40. AGEMY L , Harmelin A, Waks T, Leibovitch I, et al
    Irradiation enhances the metastatic potential of prostatic small cell carcinoma xenografts.
    Prostate. 2008;68:530-9.
    PubMed     Related articles    Abstract available
    
    
    
41. JEET V , Ow K, Doherty E, Curley B, et al
    Broadening of transgenic adenocarcinoma of the mouse prostate (TRAMP) model to represent late stage androgen depletion independent cancer.
    Prostate. 2008;68:548-62.
    PubMed     Related articles    Abstract available
    
    
    
42. ZENZMAIER C , Untergasser G, Hermann M, Dirnhofer S, et al
    Dysregulation of Dkk-3 expression in benign and malignant prostatic tissue.
    Prostate. 2008;68:540-7.
    PubMed     Related articles    Abstract available
    
    
    March 2008
43. JIANG M , Li M, Fu X, Huang Y, et al
    Simultaneously detection of genomic and expression alterations in prostate cancer using cDNA microarray.
    Prostate. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
44. TROYER DA , Tang Y, Bedolla R, Adhvaryu SG, et al
    Characterization of PacMetUT1, a recently isolated human prostate cancer cell line.
    Prostate. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
45. HORIGUCHI A , Zheng R, Shen R, Nanus DM, et al
    Inactivation of the NF2 tumor suppressor protein merlin in DU145 prostate cancer cells.
    Prostate. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
46. SUN J , Purcell L, Gao Z, Isaacs SD, et al
    Association between sequence variants at 17q12 and 17q24.3 and prostate cancer risk in European and African Americans.
    Prostate. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
47. MORGAN TM , Pitts TE, Gross TS, Poliachik SL, et al
    RAD001 (Everolimus) inhibits growth of prostate cancer in the bone and the inhibitory effects are increased by combination with docetaxel and zoledronic acid.
    Prostate. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
48. FESTUCCIA C , Gravina GL, Muzi P, Millimaggi D, et al
    Akt down-modulation induces apoptosis of human prostate cancer cells and synergizes with EGFR tyrosine kinase inhibitors.
    Prostate. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
49. IGNATOSKI KM , Escara-Wilke JF, Dai JL, Lui A, et al
    RANKL inhibition is an effective adjuvant for docetaxel in a prostate cancer bone metastases model.
    Prostate. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
50. RICCIARDELLI C , Jackson MW, Choong CS, Stahl J, et al
    Elevated levels of HER-2/neu and androgen receptor in clinically localized prostate cancer identifies metastatic potential.
    Prostate. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
51. JIA L , Yu W, Wang P, Sanders BG, et al
    In vivo and in vitro studies of anticancer actions of alpha-TEA for human prostate cancer cells.
    Prostate. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
52. WANG W , Rayburn ER, Hao M, Zhao Y, et al
    Experimental therapy of prostate cancer with novel natural product anti-cancer ginsenosides.
    Prostate. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
53. GRAVINA GL , Festuccia C, Millimaggi D, Dolo V, et al
    Chronic azacitidine treatment results in differentiating effects, sensitizes against bicalutamide in androgen-independent prostate cancer cells.
    Prostate. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
54. MACOSKA JA , Begley LA, Dunn RL, Siddiqui J, et al
    Pilot and feasibility study of serum chemokines as markers to distinguish prostatic disease in men with low total serum PSA.
    Prostate. 2008;68:442-52.
    PubMed     Related articles    Abstract available
    
    
    
55. MINELLI A , Bellezza I, Tucci A, Conte C, et al
    2-chloroadenosine modulates PAR-1 and IL-23 expression and enhances docetaxel effects on PC3 cells.
    Prostate. 2008;68:360-72.
    PubMed     Related articles    Abstract available
    
    
    
56. RUNDLE A , Neugut AI
    Obesity and screening PSA levels among men undergoing an annual physical exam.
    Prostate. 2008;68:373-80.
    PubMed     Related articles    Abstract available
    
    
    
57. PALMER J , Venkateswaran V, Fleshner NE, Klotz LH, et al
    The impact of diet and micronutrient supplements on the expression of neuroendocrine markers in murine Lady transgenic prostate.
    Prostate. 2008;68:345-53.
    PubMed     Related articles    Abstract available
    
    
    February 2008
58. CHO KS , Lee JS, Cho NH, Park K, et al
    Gene amplification and mutation analysis of epidermal growth factor receptor in hormone refractory prostate cancer.
    Prostate. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
59. NEELEY YC , Arredouani MS, Hollenbeck B, Eng MH, et al
    Partially circumventing peripheral tolerance for oncogene-specific prostate cancer immunotherapy.
    Prostate. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
60. GOODWIN AC , Jadallah S, Toubaji A, Lecksell K, et al
    Increased spermine oxidase expression in human prostate cancer and prostatic intraepithelial neoplasia tissues.
    Prostate. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
61. ALLMEN EU , Koch M, Fritz G, Legler DF, et al
    V domain of RAGE interacts with AGEs on prostate carcinoma cells.
    Prostate. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
62. D'ANTONIO JM , Ma C, Monzon FA, Pflug BR, et al
    Longitudinal analysis of androgen deprivation of prostate cancer cells identifies pathways to androgen independence.
    Prostate. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
63. AGALLIU I , Suuriniemi M, Prokunina-Olsson L, Johanneson B, et al
    Evaluation of a variant in the transcription factor 7-like 2 (TCF7L2) gene and prostate cancer risk in a population-based study.
    Prostate. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
64. CHOW L , Rezmann L, Imamura K, Wang L, et al
    Functional angiotensin II type 2 receptors inhibit growth factor signaling in LNCaP and PC3 prostate cancer cell lines.
    Prostate. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
65. ANGELUCCI A , Muzi P, Cristiano L, Millimaggi D, et al
    Neuroendocrine transdifferentiation induced by VPA is mediated by PPARgamma activation and confers resistance to antiblastic therapy in prostate carcinoma.
    Prostate. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
66. TISCHKOWITZ M , Sabbaghian N, Ray AM, Lange EM, et al
    Analysis of the gene coding for the BRCA2-Interacting protein PALB2 in hereditary prostate cancer.
    Prostate. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
67. MABJEESH NJ , Shefler A, Amir S, Matzkin H, et al
    Potentiation of 2-Methoxyestradiol-Induced cytotoxicity by blocking endothelin A receptor in prostate cancer cells.
    Prostate. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
68. BERRY LJ , Au GG, Barry RD, Shafren DR, et al
    Potent Oncolytic activity of human enteroviruses against human prostate cancer.
    Prostate. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
69. MORIKAWA A , Varma V, Gillespie TW, Lyles RH, et al
    Counting alleles in single lesions of prostate tumors from ethnically diverse patients.
    Prostate. 2008;68:231-40.
    PubMed     Related articles    Abstract available
    
    
    
70. OLSSON M , Lindstrom S, Haggkvist B, Adami HO, et al
    The UGT2B17 gene deletion is not associated with prostate cancer risk.
    Prostate. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
71. SERDA RE , Bisoffi M, Thompson TA, Ji M, et al
    1alpha,25-Dihydroxyvitamin D(3) down-regulates expression of prostate specific membrane antigen in prostate cancer cells.
    Prostate. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
72. STROM SS , Yamamura Y, Flores-Sandoval FN, Pettaway CA, et al
    Prostate cancer in Mexican-Americans: Identification of risk factors.
    Prostate. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
73. KUNDU SD , Lee C, Billips BK, Habermacher GM, et al
    The toll-like receptor pathway: a novel mechanism of infection-induced carcinogenesis of prostate epithelial cells.
    Prostate. 2008;68:223-9.
    PubMed     Related articles    Abstract available
    
    
    
74. MOORE ML , Teitell MA, Kim Y, Watabe T, et al
    Deletion of PSCA increases metastasis of TRAMP-induced prostate tumors without altering primary tumor formation.
    Prostate. 2008;68:139-51.
    PubMed     Related articles    Abstract available
    
    
    
75. VAN WIJNGAARDEN E , Singer EA, Palapattu GS
    Prostate-specific antigen levels in relation to cadmium exposure and zinc intake: results from the 2001-2002 National Health and Nutrition Examination Survey.
    Prostate. 2008;68:122-8.
    PubMed     Related articles    Abstract available
    
    
    January 2008
76. PIENTA KJ , Abate-Shen C, Agus DB, Attar RM, et al
    The current state of preclinical prostate cancer animal models.
    Prostate. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
77. SUN J , Lange EM, Isaacs SD, Liu W, et al
    Chromosome 8q24 risk variants in hereditary and non-hereditary prostate cancer patients.
    Prostate. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
78. SERKOVA NJ , Gamito EJ, Jones RH, O'Donnell C, et al
    The metabolites citrate, myo-inositol, and spermine are potential age-independent markers of prostate cancer in human expressed prostatic secretions.
    Prostate. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
79. GREGORAKIS AK , Stefanakis S, Malovrouvas D, Petraki K, et al
    Total and free PSA kinetics in patients without prostate cancer undergoing radical cystoprostatectomy.
    Prostate. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
80. AITCHISON AA , Veerakumarasivam A, Vias M, Kumar R, et al
    Promoter methylation correlates with reduced Smad4 expression in advanced prostate cancer.
    Prostate. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
81. MU Z , Hachem P, Hensley H, Stoyanova R, et al
    Antisense MDM2 enhances the response of androgen insensitive human prostate cancer cells to androgen deprivation in vitro and in vivo.
    Prostate. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
82. KAUSHAL A , Myers SA, Dong Y, Lai J, et al
    A novel transcript from the KLKP1 gene is androgen regulated, down-regulated during prostate cancer progression and encodes the first non-serine protease identified from the human kallikrein gene locus.
    Prostate. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
83. DANFORTH KN , Rodriguez C, Hayes RB, Sakoda LC, et al
    TNF polymorphisms and prostate cancer risk.
    Prostate. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
84. SUN A , Tang J, Hong Y, Song J, et al
    Androgen receptor-dependent regulation of Bcl-xL expression: Implication in prostate cancer progression.
    Prostate. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
85. LAI CL , van den Ham R, van Leenders G, van der Lugt J, et al
    Histopathological and immunohistochemical characterization of canine prostate cancer.
    Prostate. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
86. SROKA IC , McDaniel K, Nagle RB, Bowden GT, et al
    Differential localization of MT1-MMP in human prostate cancer tissue: Role of IGF-1R in MT1-MMP expression.
    Prostate. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
87. JIA L , Yu W, Wang P, Li J, et al
    Critical roles for JNK, c-Jun, and Fas/FasL-Signaling in vitamin E analog-induced apoptosis in human prostate cancer cells.
    Prostate. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
88. MIZUMACHI T , Muskhelishvili L, Naito A, Furusawa J, et al
    Increased distributional variance of mitochondrial DNA content associated with prostate cancer cells as compared with normal prostate cells.
    Prostate. 2008;.
    PubMed     Related articles    Abstract available   Free Full Text
    
    
    
89. LIU JW , Nagpal JK, Jeronimo C, Lee JE, et al
    Hypermethylation of MCAM gene is associated with advanced tumor stage in prostate cancer.
    Prostate. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
90. SHEA PR , Ishwad CS, Bunker CH, Patrick AL, et al
    RNASEL and RNASEL-inhibitor variation and prostate cancer risk in Afro-Caribbeans.
    Prostate. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
91. NARITA S , Tsuchiya N, Saito M, Inoue T, et al
    Candidate genes involved in enhanced growth of human prostate cancer under high fat feeding identified by microarray analysis.
    Prostate. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
92. ARMSTRONG AP , Miller RE, Jones JC, Zhang J, et al
    RANKL acts directly on RANK-expressing prostate tumor cells and mediates migration and expression of tumor metastasis genes.
    Prostate. 2008;68:92-104.
    PubMed     Related articles    Abstract available
    
    
    
93. GUPTA A , Wang Y, Browne C, Kim S, et al
    Neuroendocrine differentiation in the 12T-10 transgenic prostate mouse model mimics endocrine differentiation of pancreatic beta cells.
    Prostate. 2008;68:50-60.
    PubMed     Related articles    Abstract available
    
    
    
94. LOCKE JA , Wasan KM, Nelson CC, Guns ES, et al
    Androgen-mediated cholesterol metabolism in LNCaP and PC-3 cell lines is regulated through two different isoforms of acyl-coenzyme A:Cholesterol Acyltransferase (ACAT).
    Prostate. 2008;68:20-33.
    PubMed     Related articles    Abstract available
    
    
    December 2007
95. ZHU ML , Partin JV, Bruckheimer EM, Strup SE, et al
    TGF-beta signaling and androgen receptor status determine apoptotic cross-talk in human prostate cancer cells.
    Prostate. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
96. SARMA AV , Dunn RL, Lange LA, Ray A, et al
    Genetic polymorphisms in CYP17, CYP3A4, CYP19A1, SRD5A2, IGF-1, and IGFBP-3 and prostate cancer risk in African-American men: The Flint Men's Health Study.
    Prostate. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
97. SFANOS KS , Sauvageot J, Fedor HL, Dick JD, et al
    A molecular analysis of prokaryotic and viral DNA sequences in prostate tissue from patients with prostate cancer indicates the presence of multiple and diverse microorganisms.
    Prostate. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
98. SHAIDA N , Launchbury R, Boddy JL, Jones C, et al
    Expression of BNIP3 correlates with hypoxia-inducible factor (HIF)-1alpha, HIF-2alpha and the androgen receptor in prostate cancer and is regulated directly by hypoxia but not androgens in cell lines.
    Prostate. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
99. LANGSENLEHNER T , Langsenlehner U, Renner W, Kapp KS, et al
    The Glu228Ala polymorphism in the ligand binding domain of death receptor 4 is associated with increased risk for prostate cancer metastases.
    Prostate. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
100. HELLSTEN R , Johansson M, Dahlman A, Dizeyi N, et al
     Galiellalactone is a novel therapeutic candidate against hormone-refractory prostate cancer expressing activated Stat3.
     Prostate. 2007;.
     PubMed     Related articles    Abstract available
     
     
     
101. SONG Y , Tangen C, Goodman P, Parnes HL, et al
     Finasteride, prostate cancer, and weight gain: Evidence for genetic or environmental factors that affect cancer outcomes during finasteride treatment.
     Prostate. 2007;.
     PubMed     Related articles    Abstract available
     
     
     
102. BRYANT RJ , Winder SJ, Cross SS, Hamdy FC, et al
     The polycomb group protein EZH2 regulates actin polymerization in human prostate cancer cells.
     Prostate. 2007;.
     PubMed     Related articles    Abstract available
     
     
     
103. WALTON TJ , Li G, Seth R, McArdle SE, et al
     DNA demethylation and histone deacetylation inhibition co-operate to re-express estrogen receptor beta and induce apoptosis in prostate cancer cell-lines.
     Prostate. 2007;.
     PubMed     Related articles    Abstract available
     
     
     
104. MAKAROV DV , Marlow C, Epstein JI, Miller MC, et al
     Using nuclear morphometry to predict the need for treatment among men with low grade, low stage prostate cancer enrolled in a program of expectant management with curative intent.
     Prostate. 2007;.
     PubMed     Related articles    Abstract available
     
     
     
105. ZHIGANG Z , Wenlu S
     The association of prostate stem cell antigen (PSCA) mRNA expression and subsequent prostate cancer risk in men with benign prostatic hyperplasia following transurethral resection of the prostate.
     Prostate. 2007;.
     PubMed     Related articles    Abstract available
     
     
     
106. GUSTAVSSON H , Jennbacken K, Welen K, Damber JE, et al
     Altered expression of genes regulating angiogenesis in experimental androgen-independent prostate cancer.
     Prostate. 2007;.
     PubMed     Related articles    Abstract available
     
     
     
107. THORPE JA , Christian PA, Schwarze SR
     Proteasome inhibition blocks caspase-8 degradation and sensitizes prostate cancer cells to death receptor-mediated apoptosis.
     Prostate. 2007;.
     PubMed     Related articles    Abstract available
     
     
     
108. BETHEL CR , Bieberich CJ
     Loss of Nkx3.1 expression in the transgenic adenocarcinoma of mouse prostate model.
     Prostate. 2007;67:1740-50.
     PubMed     Related articles    Abstract available
     
     
     
109. QIAO Y , Zhang ZK, Cai LQ, Tan C, et al
     17alpha-estradiol inhibits LAPC-4 prostatic tumor cell proliferation in cell cultures and tumor growth in xenograft animals.
     Prostate. 2007;67:1719-28.
     PubMed     Related articles    Abstract available
     
     
     November 2007
110. MEHROTRA J , Varde S, Wang H, Chiu H, et al
     Quantitative, spatial resolution of the epigenetic field effect in prostate cancer.
     Prostate. 2007;.
     PubMed     Related articles    Abstract available
     
     
     
111. WOLF P , Alt K, Buhler P, Katzenwadel A, et al
     Anti-PSMA immunotoxin as novel treatment for prostate cancer? High and specific antitumor activity on human prostate xenograft tumors in SCID mice.
     Prostate. 2007;.
     PubMed     Related articles    Abstract available
     
     
     
112. CHIU FL , Lin JK
     Downregulation of androgen receptor expression by luteolin causes inhibition of cell proliferation and induction of apoptosis in human prostate cancer cells and xenografts.
     Prostate. 2007;.
     PubMed     Related articles    Abstract available
     
     
     
113. MERSEBURGER AS , Kramer MW, Hennenlotter J, Simon P, et al
     Involvement of decreased Galectin-3 expression in the pathogenesis and progression of prostate cancer.
     Prostate. 2007;.
     PubMed     Related articles    Abstract available
     
     
     
114. SAHA B , Arase A, Imam SS, Tsao-Wei D, et al
     Overexpression of E-cadherin and beta-Catenin proteins in metastatic prostate cancer cells in bone.
     Prostate. 2007;.
     PubMed     Related articles    Abstract available
     
     
     
115. LEE SO , Pinder E, Chun JY, Lou W, et al
     Interleukin-4 stimulates androgen-independent growth in LNCaP human prostate cancer cells.
     Prostate. 2007;.
     PubMed     Related articles    Abstract available
     
     
     
116. HIGUCHI T , Nakamura M, Shimada K, Ishida E, et al
     HRK inactivation associated with promoter methylation and LOH in prostate cancer.
     Prostate. 2007;.
     PubMed     Related articles    Abstract available
     
     
     
117. ELLINGER J , Haan K, Heukamp LC, Kahl P, et al
     CpG Island hypermethylation in cell-free serum DNA identifies patients with localized prostate cancer.
     Prostate. 2007;.
     PubMed     Related articles    Abstract available
     
     
     
118. FREEDLAND SJ , Mavropoulos J, Wang A, Darshan M, et al
     Carbohydrate restriction, prostate cancer growth, and the insulin-like growth factor axis.
     Prostate. 2007;.
     PubMed     Related articles    Abstract available
     
     
     
119. LEROUX ME , Auzenne E, Evans R, Hail N Jr, et al
     Sphingolipids and the sphingosine kinase inhibitor, SKI II, induce BCL-2-independent apoptosis in human prostatic adenocarcinoma cells.
     Prostate. 2007;67:1699-717.
     PubMed     Related articles    Abstract available
     
     
     
120. GARCIA FU , Haber MM, Chen X
     Prostatic basal cells in the peripheral and transitional zones: zonal variation in morphology and in immunophenotype.
     Prostate. 2007;67:1686-92.
     PubMed     Related articles    Abstract available
     
     
     October 2007
121. EBELT K , Babaryka G, Figel AM, Pohla H, et al
     Dominance of CD4(+) lymphocytic infiltrates with disturbed effector cell characteristics in the tumor microenvironment of prostate carcinoma.
     Prostate. 2007;.
     PubMed     Related articles    Abstract available
     
     
     
122. WANG D , Lu S, Dong Z
     Regulation of TGF-beta1 gene transcription in human prostate cancer cells by nitric oxide.
     Prostate. 2007;.
     PubMed     Related articles    Abstract available
     
     
     
123. TARAROVA ND , Narizhneva N, Krivokrisenko V, Gudkov AV, et al
     Prostate cancer cells tolerate a narrow range of androgen receptor expression and activity.
     Prostate. 2007;.
     PubMed     Related articles    Abstract available
     
     
     
124. LEIBLICH A , Cross SS, Catto JW, Pesce G, et al
     Human prostate cancer cells express neuroendocrine cell markers PGP 9.5 and chromogranin A.
     Prostate. 2007;.
     PubMed     Related articles    Abstract available
     
     
     
125. CAO KY , Mao XP, Wang DH, Xu L, et al
     High expression of PSM-E correlated with tumor grade in prostate cancer: A new alternatively spliced variant of prostate-specific membrane antigen.
     Prostate. 2007;.
     PubMed     Related articles    Abstract available
     
     
     
126. DUBOVSKY JA , McNeel DG
     Inducible expression of a prostate cancer-testis antigen, SSX-2, following treatment with a DNA methylation inhibitor.
     Prostate. 2007;.
     PubMed     Related articles    Abstract available
     
     
     
127. WLAZLINSKI A , Engers R, Hoffmann MJ, Hader C, et al
     Downregulation of several fibulin genes in prostate cancer.
     Prostate. 2007;.
     PubMed     Related articles    Abstract available
     
     
     
128. PROWALD A , Cronauer MV, von Klot C, Eilers T, et al
     Modulation of beta-catenin-mediated TCF-signalling in prostate cancer cell lines by wild-type and mutant p53.
     Prostate. 2007;.
     PubMed     Related articles    Abstract available
     
     
     
129. BIGLER D , Gioeli D, Conaway MR, Weber MJ, et al
     Rap2 regulates androgen sensitivity in human prostate cancer cells.
     Prostate. 2007;67:1590-9.
     PubMed     Related articles    Abstract available
     
     
     
130. PARK SE , Park JW, Cho YS, Ryu JH, et al
     HIF-1alpha promotes survival of prostate cells at a high zinc environment.
     Prostate. 2007;67:1514-23.
     PubMed     Related articles    Abstract available
     
     
     September 2007
131. OLSON BM , McNeel DG
     Antibody and T-cell responses specific for the androgen receptor in patients with prostate cancer.
     Prostate. 2007;.
     PubMed     Related articles    Abstract available
     
     
     
132. MAO S , Daliani DD, Wang X, Thall PF, et al
     Employing the treatment-free interval of intermittent androgen ablation to screen candidate prostate cancer therapies.
     Prostate. 2007;67:1677-1685.
     PubMed     Related articles    Abstract available
     
     
     
133. PARIS PL , Sridharan S, Scheffer A, Tsalenko A, et al
     High resolution oligonucleotide CGH using DNA from archived prostate tissue.
     Prostate. 2007;67:1447-55.
     PubMed     Related articles    Abstract available
     
     
     
134. MEMARI N , Diamandis EP, Earle T, Campbell A, et al
     Human kallikrein-related peptidase 12: antibody generation and immunohistochemical localization in prostatic tissues.
     Prostate. 2007;67:1465-74.
     PubMed     Related articles    Abstract available
     
     
     
135. OLSSON M , Gustafsson O, Skogastierna C, Tolf A, et al
     Regulation and expression of human CYP7B1 in prostate: overexpression of CYP7B1 during progression of prostatic adenocarcinoma.
     Prostate. 2007;67:1439-46.
     PubMed     Related articles    Abstract available
     
     
     
136. BROWN MD , Gilmore PE, Hart CA, Samuel JD, et al
     Characterization of benign and malignant prostate epithelial Hoechst 33342 side populations.
     Prostate. 2007;67:1384-96.
     PubMed     Related articles    Abstract available
     
     
     
137. PRESCOTT J , Jariwala U, Jia L, Cogan JP, et al
     Androgen receptor-mediated repression of novel target genes.
     Prostate. 2007;67:1371-83.
     PubMed     Related articles    Abstract available
     
     
     
138. JOHANSSON A , Jones J, Pietras K, Kilter S, et al
     A stroma targeted therapy enhances castration effects in a transplantable rat prostate cancer model.
     Prostate. 2007;.
     PubMed     Related articles    Abstract available
     
     
     
139. NESLUND-DUDAS C , Bock CH, Monaghan K, Nock NL, et al
     SRD5A2 and HSD3B2 polymorphisms are associated with prostate cancer risk and aggressiveness.
     Prostate. 2007;.
     PubMed     Related articles    Abstract available   Free Full Text
     
     
     
140. ZHANG AL , Russell PJ, Knittel T, Milross C, et al
     Paclitaxel enhanced radiation sensitization for the suppression of human prostate cancer tumor growth via a p53 independent pathway.
     Prostate. 2007;.
     PubMed     Related articles    Abstract available
     
     
     
141. GILL C , Walsh SE, Morrissey C, Fitzpatrick JM, et al
     Resveratrol sensitizes androgen independent prostate cancer cells to death-receptor mediated apoptosis through multiple mechanisms.
     Prostate. 2007;.
     PubMed     Related articles    Abstract available
     
     
     
142. CHOO R , Danjoux C, Morton G, Szumacher E, et al
     How much does Gleason grade of follow-up biopsy differ from that of initial biopsy in untreated, Gleason score 4-7, clinically localized prostate cancer?
     Prostate. 2007;.
     PubMed     Related articles    Abstract available
     
     
     
143. STANGELBERGER A , Schally AV, Zarandi M, Heinrich E, et al
     The combination of antagonists of LHRH with antagonists of GHRH improves inhibition of androgen sensitive MDA-PCa-2b and LuCaP-35 prostate cancers.
     Prostate. 2007;67:1339-53.
     PubMed     Related articles    Abstract available
     
     
     
144. WIKSTROM P , Ohlson N, Stattin P, Bergh A, et al
     Nuclear androgen receptors recur in the epithelial and stromal compartments of malignant and non-malignant human prostate tissue several months after castration therapy.
     Prostate. 2007;67:1277-84.
     PubMed     Related articles    Abstract available
     
     
     August 2007
145. BANU E , Banu A, Medioni J, Levy E, et al
     Serum PSA half-life as a predictor of survival for hormone-refractory prostate cancer patients: Modelization using a standardized set of response criteria.
     Prostate. 2007;.
     PubMed     Related articles    Abstract available
     
     
     
146. MITTERBERGER M , Horninger W, Pelzer A, Strasser H, et al
     A prospective randomized trial comparing contrast-enhanced targeted versus systematic ultrasound guided biopsies: Impact on prostate cancer detection.
     Prostate. 2007;.
     PubMed     Related articles    Abstract available
     
     
     
147. HARPER CE , Patel BB, Wang J, Eltoum IA, et al
     Epigallocatechin-3-Gallate suppresses early stage, but not late stage prostate cancer in TRAMP mice: Mechanisms of action.
     Prostate. 2007;.
     PubMed     Related articles    Abstract available
     
     
     
148. MALIK G , Rojahn E, Ward MD, Gretzer MB, et al
     SELDI protein profiling of dunning R-3327 derived cell lines: Identification of molecular markers of prostate cancer progression.
     Prostate. 2007;.
     PubMed     Related articles    Abstract available
     
     
     
149. DAS S , Roth CP, Wasson LM, Vishwanatha JK, et al
     Signal transducer and activator of transcription-6 (STAT6) is a constitutively expressed survival factor in human prostate cancer.
     Prostate. 2007;.
     PubMed     Related articles    Abstract available
     
     
     
150. LEVIN AM , Zuhlke KA, Ray AM, Cooney KA, et al
     Sequence variation in alpha-methylacyl-CoA racemase and risk of early-onset and familial prostate cancer.
     Prostate. 2007;.
     PubMed     Related articles    Abstract available
     
     
     
151. VENKATARAMAN G , Heinze G, Holmes EW, Ananthanarayanan V, et al
     Identification of patients with low-risk for aneuploidy: Comparative discriminatory models using linear and machine-learning classifiers in prostate cancer.
     Prostate. 2007;.
     PubMed     Related articles    Abstract available
     
     
     
152. DAUGHERTY SE , Shugart YY, Platz EA, Fallin MD, et al
     Polymorphic variants in alpha-methylacyl-CoA racemase and prostate cancer.
     Prostate. 2007;.
     PubMed     Related articles    Abstract available
     
     
     
153. WU W , Zanello L, Walker AM
     S179D prolactin sensitizes human prostate cancer cells such that physiological concentrations of 1, 25 dihydroxy vitamin D3 result in growth inhibition and cell death.
     Prostate. 2007;.
     PubMed     Related articles    Abstract available
     
     
     
154. WANG W , Bergh A, Damber JE
     Increased expression of CCAAT/enhancer-binding protein beta in proliferative inflammatory atrophy of the prostate: relation with the expression of COX-2, the androgen receptor, and presence of focal chronic inflammation.
     Prostate. 2007;67:1238-46.
     PubMed     Related articles    Abstract available
     
     
     
155. MONSEF N , Helczynski L, Lundwall A, Pahlman S, et al
     Localization of immunoreactive HIF-1alpha and HIF-2alpha in neuroendocrine cells of both benign and malignant prostate glands.
     Prostate. 2007;67:1219-29.
     PubMed     Related articles    Abstract available
     
     
     
156. VELTRI RW , Marlow C, Khan MA, Miller MC, et al
     Significant variations in nuclear structure occur between and within Gleason grading patterns 3, 4, and 5 determined by digital image analysis.
     Prostate. 2007;67:1202-10.
     PubMed     Related articles    Abstract available
     
     
     July 2007
157. LEONETTI C , Biroccio A, D'Angelo C, Semple SC, et al
     Therapeutic integration of c-myc and bcl-2 antisense molecules with docetaxel in a preclinical model of hormone-refractory prostate cancer.
     Prostate. 2007;67:1475-1485.
     PubMed     Related articles    Abstract available
     
     
     
158. CAMP NJ , Farnham JM, Allen-Brady K, Cannon-Albright LA, et al
     Statistical recombinant mapping in extended high-risk Utah pedigrees narrows the 8q24 prostate cancer locus to 2.0 Mb.
     Prostate. 2007;67:1456-1464.
     PubMed     Related articles    Abstract available
     
     
     
159. VAN OORT IM , Tomita K, van Bokhoven A, Bussemakers MJ, et al
     The prognostic value of E-cadherin and the cadherin-associated molecules alpha-, beta-, gamma-catenin and p120(ctn) in prostate cancer specific survival: A long-term follow-up study.
     Prostate. 2007;.
     PubMed     Related articles    Abstract available
     
     
     
160. ASIRVATHAM AJ , Carey JP, Chaudhary J
     ID1-, ID2-, and ID3-regulated gene expression in E2A positive or negative prostate cancer cells.
     Prostate. 2007;.
     PubMed     Related articles    Abstract available
     
     
     
161. HE D , Falany CN
     Inhibition of SULT2B1b expression alters effects of 3beta-hydroxysteroids on cell proliferation and steroid hormone receptor expression in human LNCaP prostate cancer cells.
     Prostate. 2007;67:1318-1329.
     PubMed     Related articles    Abstract available
     
     
     
162. PINTHUS JH , Lu JP, Bidaisee LA, Lin H, et al
     Androgen-dependent regulation of medium and long chain fatty acids uptake in prostate cancer.
     Prostate. 2007;67:1330-1338.
     PubMed     Related articles    Abstract available
     
     
     
163. STEWART GD , Lowrie AG, Riddick AC, Fearon KC, et al
     Dermcidin expression confers a survival advantage in prostate cancer cells subjected to oxidative stress or hypoxia.
     Prostate. 2007;67:1308-1317.
     PubMed     Related articles    Abstract available
     
     
     
164. LEE SO , Dutt SS, Nadiminty N, Pinder E, et al
     Development of an androgen-deprivation induced and androgen suppressed human prostate cancer cell line.
     Prostate. 2007;67:1293-1300.
     PubMed     Related articles    Abstract available
     
     
     
165. LUDWIG S , Stephan C, Lein M, Loening SA, et al
     S100A8, S100A9, and the S100A8/A9 complex in circulating blood are not associated with prostate cancer risk-A re-evaluation study.
     Prostate. 2007;67:1301-1307.
     PubMed     Related articles    Abstract available
     
     
     
166. LI H , Bubley GJ, Balk SP, Gaziano JM, et al
     Hypoxia-inducible factor-1alpha (HIF-1alpha) gene polymorphisms, circulating insulin-like growth factor binding protein (IGFBP)-3 levels and prostate cancer.
     Prostate. 2007;67:1354-1361.
     PubMed     Related articles    Abstract available
     
     
     
167. LAGUNOVA Z , Porojnicu AC, Dahlback A, Berg JP, et al
     Prostate cancer survival is dependent on season of diagnosis.
     Prostate. 2007;67:1362-1370.
     PubMed     Related articles    Abstract available
     
     
     
168. WHITTINGTON K , Connors B, King K, Assinder S, et al
     The effect of oxytocin on cell proliferation in the human prostate is modulated by gonadal steroids: implications for benign prostatic hyperplasia and carcinoma of the prostate.
     Prostate. 2007;67:1132-42.
     PubMed     Related articles    Abstract available
     
     
     
169. MORGENROTH A , Cartellieri M, Schmitz M, Gunes S, et al
     Targeting of tumor cells expressing the prostate stem cell antigen (PSCA) using genetically engineered T-cells.
     Prostate. 2007;67:1121-31.
     PubMed     Related articles    Abstract available
     
     
     
170. SINGH SS , Mehedint DC, Ford OH 3rd, Maygarden SJ, et al
     Feasibility of constructing tissue microarrays from diagnostic prostate biopsies.
     Prostate. 2007;67:1011-8.
     PubMed     Related articles    Abstract available
     
     
     
171. KLYUSHNENKOVA EN , Kouiavskaia DV, Kodak JA, Vandenbark AA, et al
     Identification of HLA-DRB1*1501-restricted T-cell epitopes from human prostatic acid phosphatase.
     Prostate. 2007;67:1019-28.
     PubMed     Related articles    Abstract available
     
     
     June 2007
172. FESTUCCIA C , Gravina GL, Muzi P, Pomante R, et al
     In vitro and in vivo effects of bicalutamide on the expression of TrkA and P75 neurotrophin receptors in prostate carcinoma.
     Prostate. 2007;.
     PubMed     Related articles    Abstract available
     
     
     
173. WHITAKER HC , Stanbury DP, Brinham C, Girling J, et al
     Labeling and identification of LNCaP cell surface proteins: a pilot study.
     Prostate. 2007;67:943-54.
     PubMed     Related articles    Abstract available
     
     
     
174. ERIKSSON M , Wedel H, Wallander MA, Krakau I, et al
     The impact of birth weight on prostate cancer incidence and mortality in a population-based study of men born in 1913 and followed up from 50 to 85 years of age.
     Prostate. 2007;67:1247-1254.
     PubMed     Related articles    Abstract available
     
     
     
175. WIREN S , Stocks T, Rinaldi S, Hallmans G, et al
     Androgens and prostate cancer risk: A prospective study.
     Prostate. 2007;.
     PubMed     Related articles    Abstract available
     
     
     
176. VAN GILS MP , Cornel EB, Hessels D, Peelen WP, et al
     Molecular PCA3 diagnostics on prostatic fluid.
     Prostate. 2007;67:881-7.
     PubMed     Related articles    Abstract available
     
     
     
177. PENG W , Anderson DG, Bao Y, Padera RF Jr, et al
     Nanoparticulate delivery of suicide DNA to murine prostate and prostate tumors.
     Prostate. 2007;67:855-62.
     PubMed     Related articles    Abstract available
     
     
     
178. KRAAIJ R , van der Weel L, de Ridder CM, van der Korput HA, et al
     A small chimeric promoter for high prostate-specific transgene expression from adenoviral vectors.
     Prostate. 2007;67:829-39.
     PubMed     Related articles    Abstract available
     
     
     
179. URUSHIBARA M , Ishioka J, Hyochi N, Kihara K, et al
     Effects of steroidal and non-steroidal antiandrogens on wild-type and mutant androgen receptors.
     Prostate. 2007;67:799-807.
     PubMed     Related articles    Abstract available
     
     
     May 2007
180. MATHESON BK , Adams JL, Zou J, Patel R, et al
     Effect of metabolic inhibitors on ATP and citrate content in PC3 prostate cancer cells.
     Prostate. 2007;.
     PubMed     Related articles    Abstract available
     
     
     
181. QIAN DZ , Wei YF, Wang X, Kato Y, et al
     Antitumor activity of the histone deacetylase inhibitor MS-275 in prostate cancer models.
     Prostate. 2007;.
     PubMed     Related articles    Abstract available
     
     
     
182. MITTERBERGER M , Neuwirt H, Cavarretta IT, Hobisch A, et al
     Increased resistance to trail-induced apoptosis in prostate cancer cells selected in the presence of bicalutamide.
     Prostate. 2007;.
     PubMed     Related articles    Abstract available
     
     
     
183. BRYAN JN , Keeler MR, Henry CJ, Bryan ME, et al
     A population study of neutering status as a risk factor for canine prostate cancer.
     Prostate. 2007;.
     PubMed     Related articles    Abstract available
     
     
     
184. SUZUKI K , Nakamura K, Kato K, Hamada H, et al
     Exploration of target molecules for prostate cancer gene therapy.
     Prostate. 2007;.
     PubMed     Related articles    Abstract available
     
     
     
185. PRIULLA M , Calastretti A, Bruno P, Amalia A, et al
     Preferential chemosensitization of PTEN-mutated prostate cells by silencing the Akt kinase.
     Prostate. 2007;67:782-9.
     PubMed     Related articles    Abstract available
     
     
     
186. DALRYMPLE SL , Becker RE, Isaacs JT
     The quinoline-3-carboxamide anti-angiogenic agent, tasquinimod, enhances the anti-prostate cancer efficacy of androgen ablation and taxotere without effecting serum PSA directly in human xenografts.
     Prostate. 2007;67:790-7.
     PubMed     Related articles    Abstract available
     
     
     
187. EILERS T , Machtens S, Tezval H, Blaue C, et al
     Prospective diagnostic efficiency of biopsy washing DNA GSTP1 island hypermethylation for detection of adenocarcinoma of the prostate.
     Prostate. 2007;67:757-63.
     PubMed     Related articles    Abstract available
     
     
     
188. RAJESHKUMAR NV , Matwyshyn G, Gulati A
     IRL-1620, a tumor selective vasodilator, augments the uptake and efficacy of chemotherapeutic agents in prostate tumor rats.
     Prostate. 2007;67:701-13.
     PubMed     Related articles    Abstract available
     
     
     
189. SUN J , Liu W, Adams TS, Sun J, et al
     DNA copy number alterations in prostate cancers: a combined analysis of published CGH studies.
     Prostate. 2007;67:692-700.
     PubMed     Related articles    Abstract available
     
     
     
190. ZHIGANG Z , Wenlu S
     Prostate stem cell antigen (PSCA) mRNA expression in prostatic intraepithelial neoplasia: implications for the development of prostate cancer.
     Prostate. 2007;.
     PubMed     Related articles    Abstract available
     
     
     
191. ARNOLD JT , Liu X, Allen JD, Le H, et al
     Androgen receptor or estrogen receptor-beta blockade alters DHEA-, DHT-, and E(2)-induced proliferation and PSA production in human prostate cancer cells.
     Prostate. 2007;.
     PubMed     Related articles    Abstract available
     
     
     
192. SHABBEER S , S Q Kortenhorst M, Kachhap S, Galloway N, et al
     Multiple Molecular pathways explain the anti-proliferative effect of valproic acid on prostate cancer cells in vitro and in vivo.
     Prostate. 2007;.
     PubMed     Related articles    Abstract available
     
     
     
193. BANHAM AH , Boddy J, Launchbury R, Han C, et al
     Expression of the forkhead transcription factor FOXP1 is associated both with hypoxia inducible factors (HIFs) and the Androgen receptor in prostate cancer but is not directly regulated by Androgens or hypoxia.
     Prostate. 2007;.
     PubMed     Related articles    Abstract available
     
     
     
194. SCHMIDT LJ , Ballman KV, Tindall DJ
     Inhibition of fatty acid synthase activity in prostate cancer cells by dutasteride.
     Prostate. 2007;.
     PubMed     Related articles    Abstract available
     
     
     
195. HORVATH LG , Lelliott JE, Kench JG, Lee CS, et al
     Secreted frizzled-related protein 4 inhibits proliferation and metastatic potential in prostate cancer.
     Prostate. 2007;.
     PubMed     Related articles    Abstract available
     
     
     
196. AITCHISON A , Warren A, Neal D, Rabbitts P, et al
     RASSF1A promoter methylation is frequently detected in both pre-malignant and non-malignant microdissected prostatic epithelial tissues.
     Prostate. 2007;67:638-44.
     PubMed     Related articles    Abstract available
     
     
     
197. FUSE H , Korenaga S, Sakari M, Hiyama T, et al
     Non-steroidal antiandrogens act as AF-1 agonists under conditions of high androgen-receptor expression.
     Prostate. 2007;67:630-7.
     PubMed     Related articles    Abstract available
     
     
     
198. WADSWORTH TL , Worstell TR, Greenberg NM, Roselli CE, et al
     Effects of dietary saw palmetto on the prostate of transgenic adenocarcinoma of the mouse prostate model (TRAMP).
     Prostate. 2007;67:661-73.
     PubMed     Related articles    Abstract available
     
     
     April 2007
199. OH HY , Lee EJ, Yoon S, Chung BH, et al
     Cholesterol level of lipid raft microdomains regulates apoptotic cell death in prostate cancer cells through EGFR-mediated Akt and ERK signal transduction.
     Prostate. 2007;.
     PubMed     Related articles    Abstract available
     
     
     
200. ROEMELING S , Roobol MJ, Otto SJ, Habbema DF, et al
     Feasibility study of adjustment for contamination and non-compliance in a prostate cancer screening trial.
     Prostate. 2007;.
     PubMed     Related articles    Abstract available
     
     
     
201. KUMAGAI J , Fujimura T, Takahashi S, Urano T, et al
     Cytochrome P450 2B6 is a growth-inhibitory and prognostic factor for prostate cancer.
     Prostate. 2007;.
     PubMed     Related articles    Abstract available
     
     
     
202. GHOSH R , Gu G, Tillman E, Yuan J, et al
     Increased expression and differential phosphorylation of stathmin may promote prostate cancer progression.
     Prostate. 2007;.
     PubMed     Related articles    Abstract available
     
     
     
203. LOGAN IR , McNeill HV, Cook S, Lu X, et al
     Analysis of the MDM2 antagonist nutlin-3 in human prostate cancer cells.
     Prostate. 2007;.
     PubMed     Related articles    Abstract available
     
     
     
204. YONOU H , Ochiai A, Ashimine S, Maeda H, et al
     The bisphosphonate YM529 inhibits osteoblastic bone tumor proliferation of prostate cancer.
     Prostate. 2007;.
     PubMed     Related articles    Abstract available
     
     
     
205. SUN A , Shanmugam I, Song J, Terranova PF, et al
     Lithium suppresses cell proliferation by interrupting E2F-DNA interaction and subsequently reducing S-phase gene expression in prostate cancer.
     Prostate. 2007;.
     PubMed     Related articles    Abstract available
     
     
     
206. ISHIGURO H , Ishiguro Y, Kubota Y, Uemura H, et al
     Regulation of prostate cancer cell growth and PSA expression by angiotensin II receptor blocker with peroxisome proliferator-activated receptor gamma ligand like action.
     Prostate. 2007;.
     PubMed     Related articles    Abstract available
     
     
     
207. TAKEDA M , Mizokami A, Mamiya K, Li YQ, et al
     The establishment of two paclitaxel-resistant prostate cancer cell lines and the mechanisms of paclitaxel resistance with two cell lines.
     Prostate. 2007;.
     PubMed     Related articles    Abstract available
     
     
     
208. NOGUCHI M , Yao A, Harada M, Nakashima O, et al
     Immunological evaluation of neoadjuvant peptide vaccination before radical prostatectomy for patients with localized prostate cancer.
     Prostate. 2007;.
     PubMed     Related articles    Abstract available
     
     
     
209. BEN-YOSEF R , Starr A, Karaush V, Loew V, et al
     ErbB-4 may control behavior of prostate cancer cells and serve as a target for molecular therapy.
     Prostate. 2007;.
     PubMed     Related articles    Abstract available
     
     
     
210. MIKHAK B , Hunter DJ, Spiegelman D, Platz EA, et al
     Vitamin D receptor (VDR) gene polymorphisms and haplotypes, interactions with plasma 25-hydroxyvitamin D and 1,25-dihydroxyvitamin D, and prostate cancer risk.
     Prostate. 2007;.
     PubMed     Related articles    Abstract available
     
     
     
211. HARLAP S , Friedlander Y, Barchana M, Calderon R, et al
     Late fetal death in offspring and subsequent incidence of prostate cancer in fathers: The Jerusalem Perinatal Study cohort.
     Prostate. 2007;.
     PubMed     Related articles    Abstract available<